key: cord-0975385-ekxawja4
authors: Alonzo Caldarelli, Agostina; Barba, Paula; Hurtado, Mariana
title: Eruptive pseudoangiomatosis and SARS‐CoV‐2 (COVID‐19) infection
date: 2021-04-13
journal: Int J Dermatol
DOI: 10.1111/ijd.15598
sha: 370b1053908f597ba8ec9f999ac78a345ef84c2d
doc_id: 975385
cord_uid: ekxawja4

nan

the first week of hospital admission for confirmed COVID-19 pneumonia. At the same time, she was receiving treatment with corticosteroids and ceftriaxone. She was discharged 2 weeks later without any sequela, but the skin lesions remained.

Physical examination revealed multiple blanchable erythematous papules ranging from 2 to 4 mm, surrounded by a pale perilesional halo (Fig. 1a,b) .

Dermoscopy revealed the presence of multiple red dots surrounded by reddish structureless areas (Fig. 2) .

Laboratory test results, including hemogram, liver function, renal function, and hemostasis, were normal.

Considering the particular clinical characteristics of this entity, the diagnosis of eruptive pseudoangiomatosis was made, and no skin biopsy was performed. Because of the benign nature of disease and the absence of symptoms, no treatment was given. The patient evolved with spontaneous remission after 2 weeks of follow-up. Eruptive pseudoangiomatosis (EP) is a rare disease characterized by acute onset of erythematous blanchable papules resembling angiomas surrounded by a pale halo, on exposed sites (face, trunk, extremities). 1-3 A prodrome of constitutional symptoms such as mild to high fever, upper respiratory infection, diarrhea, headache, and malaise heralds cutaneous eruptions. These have been described more frequently in pediatric age. [1] [2] [3] The prodrome can also be asymptomatic. 3 

A case of eruptive pseudoangiomatosis: clinical, histopathological, and dermoscopic findings

Eruptive pseudoangiomatosis: report of an adult case and unifying hypothesis of the pathogenesis of paediatric and adult cases

Eruptive pseudoangiomatosis -cherry angiomas with perilesional halo

Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?

Cutaneous manifestations of COVID-19: an evidence-based review

Funding source: None. doi: 10.1111/ijd.15598